GRI Bio (NASDAQ:GRI – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a report released on Thursday, Benzinga reports. They currently have a $10.00 price objective on the stock. HC Wainwright’s target price suggests a potential upside of 407.36% from the stock’s current price. A number of […]

Biohaven (NYSE:BHVN – Get Free Report)‘s stock had its “neutral” rating reaffirmed by equities researchers at HC Wainwright in a research report issued on Thursday, Benzinga reports. They currently have a $10.00 price objective on the stock. HC Wainwright’s price target points to a potential downside of 21.33% from the company’s previous close. Several other […]

Seaport Therapeutics (NASDAQ:SPTX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $50.00 target price on the stock. HC Wainwright’s target price indicates a potential upside of 129.89% from the stock’s […]

Polaryx Therapeutics, Inc. (NASDAQ:PLYX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five analysts that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, two have issued a buy recommendation and one […]